Year 2018 / Volume 110 / Number 8
Case Report
Liver transplantation in hemophilia A and von Willebrand disease type 3: perioperative management and post-transplant outcome

522-526

DOI: 10.17235/reed.2018.5204/2017

Cristina Alonso Madrigal, Manuela Dobón Rebollo, Viviana Laredo de la Torre, Luis Palomera Bernal, Francisco Agustín García Gil,

Abstract
Introduction: infection with the hepatitis C virus (HCV) causes significant morbidity and mortality in patients with hemophilia. Finally, patients are considered for a liver transplantation (LT) due to cirrhosis and/or hepatocellular carcinoma (HCC). Case report: we report the cases of congenital coagulopathy and HCV infection that underwent LT in our institution. There were three patients with hemophilia A and one patient with von Willebrand disease (vWD) type 3. The coagulopathy outcome, perioperative management, factor and blood product usage and post-transplant survival were assessed. The deficient factor was initially administered in a direct bolus one hour before surgery with a target level of 100 IU/dl, which was sustained until stable hemostasis was reached. All three patients with hemophilia A were cured of their coagulopathy following transplantation. Factor VIII (FVIII) was 93 IU/dl at eleven years, 59 IU/dl at 13 months and 109 IU/dl at nine months post-transplant, in each case. The mean perioperative usage of FVIII concentrates was 175 IU/kg; concentrates were infused for an average of 36 hours post-transplant. The natural course of the bleeding symptoms of the patient with type-3 vWD was attenuated, with no detectable hemostatic levels of von Willebrand factor antigen (vWF:Ag) after transplantation. Discussion: after transplantation, hemophilia A cure and improved bleeding phenotype of type-3 vWD reduced morbidity and mortality. However, potential graft reinfection with HCV and relapsing HCC cast a shadow over these optimum results.
Share Button
New comment
Comments

20/06/2020 11:10:56
tengo hemofilia A leve y soy mujer muy buen artículo!


References
1 Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet 2003; 362: 1907-1917.
2 Lewis JH, Bontempo FA, Spero JA, et al. Liver transplantation in a hemophiliac. N Engl J Med 1985; 312 (18): 1189-1190.
3 Jimenez-Yuste V, Canales M, Jara P, et al. Haemophilia A and chronic hepatopathy caused by extrahepatic biliary atresia: two congenital diseases cured by orthotopic liver transplantation Haemophilia 1997; 3 (2): 145-148.
4 Bowie EJ, Woods JE, Fass DN, et al. Liver transplantation in pigs with von Willebrand's disease. Br J Haematol 1975; 31 (1): 37-44.
5 Mannucci PM, Federici A, Cattaneo M, et al. Liver transplantation in severe von Willebrand's disease. Lancet 1991; 337:1105.
6 Yokoyama S, Bartlett A, Dar FS, et al. Outcome of liver transplantation for haemophilia. HPB (Oxford) 2011; 13 (1):40-45.
7 Aznar JA, Marco A, Parra R, et al. Liver transplantation in Spanish haemophiliacs. Haemophilia. 2012; 18 (1): e15-16.
8 Lambing A, Kuriakose P, Kachalsky E. Liver transplantation in the haemophilia patient. Haemophilia 2012; 18 (2): 300-303.
9 Batorova A, Martinowitz U. Intermittent injections vs. continuous infusion of factor VIII in haemophilia patients undergoing major surgery. Br J Haematol 2000; 110 (3): 715-720.
10 Hermans C, Altisent C, Batorova A, et al. European Haemophilia Therapy Standardisation Board. Replacement therapy for invasive procedures in patients with haemophilia: literature review, European survey and recommendations. Haemophilia 2009; 15 (3): 639-658.
11 Meijer K, Haagsma EB. HCV-related liver cancer in people with haemophilia. Haemophilia 2012; 18 (1): 17-24.
12 Lechler E, Stippel D. Liver Transplantation in a Patient with severe von Willebrand Disease Type 3: Levels of von Willebrand Factor Following Transplantation. In: Scharrer I., Schramm W. (eds) 31st Hemophilia Symposium Hamburg 2000. Springer, Berlin, Heidelberg, 2002: 210-215.
13 Schulman S, Ericzon BG, Eleborg L. Modification of von Willebrand disease after liver transplantation. Thromb Haemost 2001; 86: 1588-1589.
14 Ghinolfi D, Cecconi N, Molinari AC, et al. Liver transplantation in type III von Willebrand disease. Am J Transplant 2016; 16 (6): 1936-1937.
Related articles

Editorial

Hemophilia and hepatology, back to the future

DOI: 10.17235/reed.2024.10105/2023

Digestive Diseases Image

Posterior reversible encephalopathy syndrome (PRES) in post liver transplantation

DOI: 10.17235/reed.2022.8694/2022

Letter

Ertapenem neurotoxicity in liver transplantation

DOI: 10.17235/reed.2021.8469/2021

Digestive Diseases Image

Ischemic cholangiopathy following hepatic artery pseudoaneurysm with thrombosis

DOI: 10.17235/reed.2021.8395/2021

Editorial

Cases of liver disease lost in the health system: a call to action

DOI: 10.17235/reed.2021.8316/2021

Original

Active search for hepatitis C patients in primary care

DOI: 10.17235/reed.2021.8067/2021

Letter

EBVMCU in a liver-transplant patient

DOI: 10.17235/reed.2021.8064/2021

Original

Hepatitis C in homeless people: reaching a hard-to-reach population

DOI: 10.17235/reed.2021.7737/2020

Editorial

Screening guide for hepatitis C virus infection in Spain

DOI: 10.17235/reed.2020.7728/2020

Digestive Diseases Image

Percutaneous treatment of a splenorenal shunt with an atrial septal closure device

DOI: 10.17235/reed.2020.7701/2020

Review

Physical frailty in liver transplantation

DOI: 10.17235/reed.2020.7448/2020

Letter

Management of hepatic artery aneurysms

DOI: 10.17235/reed.2020.7219/2020

Digestive Diseases Image

Epithelioid hemangioendothelioma: a rare cause of a liver tumor

DOI: 10.17235/reed.2020.7127/2020

Special Article

Strategy for the Elimination of Hepatitis C in Cantabria

DOI: 10.17235/reed.2020.7108/2020

Editorial

Reflex testing. A key tool for the elimination of hepatitis C

DOI: 10.17235/reed.2020.7201/2020

Original

Quality of life study in asymptomatic patients with hepatitis C

DOI: 10.17235/reed.2019.6339/2019

Letter

Acute seronegative hepatitis C: two case reports

DOI: 10.17235/reed.2019.5921/2018

Letter to the Editor

Post-transplant lymphoproliferative disease after liver transplantation

DOI: 10.17235/reed.2017.5387/2017

Letter to the Editor

Liver metastasis from colorectal cancer 12 years after liver transplantation

DOI: 10.17235/reed.2017.4507/2016

Citation tools
Alonso Madrigal C, Dobón Rebollo M, Laredo de la Torre V, Palomera Bernal L, García Gil F. Liver transplantation in hemophilia A and von Willebrand disease type 3: perioperative management and post-transplant outcome. 5204/2017


Download to a citation manager

Download the citation for this article by clicking on one of the following citation managers:

Metrics
This article has received 528 visits.
This article has been downloaded 286 times.

Statistics from Dimensions


Statistics from Plum Analytics

Publication history

Received: 30/07/2017

Accepted: 14/03/2018

Online First: 22/06/2018

Published: 30/07/2018

Article revision time: 192 days

Article Online First time: 327 days

Article editing time: 365 days


Share
This article hasn't been rated yet.
Reader rating:
Valora este artículo:




Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2023 y Creative Commons. The Spanish Journal of Gastroenterology